Novel oral agent nerandomilast slowed lung capacity decline in patients with non-idiopathic pulmonary fibrosis (IPF) ...

A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...

Ten years after heading to Cannes with Alexander Payne's ‘Nebraska,' Squibb is back with ‘Eleanor the Great’ from director ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple ...

The revitalisation of GSK's blood cancer therapy Blenrep has continued with a second regulatory approval, in Japan, as a ...

A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer ...

Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock.

Bristol-Myers Squibb Co. prevailed against investor allegations it misled them about a payout tied to Food and Drug ...

Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...

Talent platform Eightfold rolled out two transformative agentic AI tools at its recent summit: AI Interviewer Agent and ...